Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational study

Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational study

Abstract Purpose Appropriate local therapy may provide survival benefits in oligometastatic non-small cell lung cancer (NSCLC) patients receiving chemotherapy or targeted therapy. However, its roles in immunotherapy-treated patients have not been fully understood. Methods PD-1/PD-L1 inhibitor-treate...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Gao, Aihua Lan, Xi Yang, Li Chu, Xiao Chu, Yue Zhou, Hongru Chen, Silai Yu, Yechun Pang, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu
Format: Article
Language:English
Published: Springer 2025-03-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Oligometastatic NSCLC
Early local therapy
Immunotherapy
NSCLC
Online Access:https://doi.org/10.1007/s00262-025-04016-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s00262-025-04016-0

Similar Items